Skip to main content
logo
BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
8.35
-0.25 (-2.91%)
Aug 7, 2025, 4:00 PM - Market closed

Aspen Technology Revenue by Segment

Period EndingMar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
Orladeyo
483.04M437.66M404.36M373.72M346.44M325.99M305.84M286.13M
Orladeyo Growth
39.43%34.26%32.21%30.61%28.15%29.55%--
Other
20.45M13.05M8.22M8.51M8.95M5.42M11.72M20.51M
Other Growth
128.43%140.72%-29.82%-58.49%-53.71%-71.75%--

Revenue by Type

Period EndingMar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
Product
497.18M442.67M404.06M373.29M345.80M324.70M312.02M301.95M
Product Growth
43.78%36.33%29.50%23.63%20.77%21.29%--
Collaborative and Other
6.30M8.04M8.52M8.95M9.59M6.72M5.54M4.70M
Collaborative and Other Growth
-34.31%19.77%53.86%90.65%186.19%115.46%--

Revenue by Geography

Period EndingMar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
US
426.15M385.96M358.41M330.57M307.48M288.36M272.55M257.39M
US Growth
38.60%33.85%31.50%28.43%26.39%27.39%--
Outside of US
56.88M51.70M45.94M43.15M38.97M37.63M33.29M28.74M
Outside of US Growth
45.98%37.39%38.00%50.14%43.94%48.88%--
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.